Detalhe da pesquisa
1.
CT angiography-based radiomics as a tool for carotid plaque characterization: a pilot study.
Radiol Med
; 127(7): 743-753, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35680773
2.
Different methods of bone marrow harvesting influence cell characteristics and purity, affecting clinical outcomes.
JVS Vasc Sci
; 4: 100130, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058747
3.
Investigation of the Bcl-2 multimerisation process: structural and functional implications.
Biochim Biophys Acta
; 1813(5): 850-7, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21320534
4.
Class III ß-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer.
J Cell Physiol
; 227(3): 1034-41, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21520077
5.
Atherosclerotic Plaque Fissuration and Clinical Outcomes in Pre-Diabetics vs. Normoglycemics Patients Affected by Asymptomatic Significant Carotid Artery Stenosis at 2 Years of Follow-Up: Role of microRNAs Modulation: The ATIMIR Study.
Biomedicines
; 9(4)2021 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917851
6.
In vivoorganized neovascularization induced by 3D bioprinted endothelial-derived extracellular vesicles.
Biofabrication
; 13(3)2021 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33434889
7.
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment.
Mol Metab
; 54: 101337, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500107
8.
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancer.
Int J Biol Markers
; 33(1): 124-131, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218693
9.
GTP is an allosteric modulator of the interaction between the guanylate-binding protein 1 and the prosurvival kinase PIM1.
Eur J Med Chem
; 91: 132-44, 2015 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-25081641
10.
Identification of the first inhibitor of the GBP1:PIM1 interaction. Implications for the development of a new class of anticancer agents against paclitaxel resistant cancer cells.
J Med Chem
; 57(19): 7916-32, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25211704